The degradation of ®brillar type II collagen is a major feature of cartilage destruction in rheumatoid arthritis (RA). Since collagenase 3 is produced by chondrocytes and preferentially degrades type II cartilage collagen, it seemed likely that this enzyme would have a prominent role in the destruction of rheumatoid joints. Using immunolocalization techniques, we have examined and compared the production and distributions of collagenase 1 and collagenase 3 in cells and tissues derived from rheumatoid knee arthroplasties. Primary cultures of chondrocytes stimulated with interleukin-1b showed that most of the cells produced collagenase 1, whereas only a minority (H5±10%) produced collagenase 3; a few chondrocytes demonstrated the co-ordinate production of both enzymes. Primary cultures of rheumatoid synoviocytes produced collagenase 1, but not collagenase 3. Both enzymes were demonstrated in the rheumatoid lesion. Collagenase 1 was more commonly observed in both synovium and cartilage (22 of the 28 specimens), was especially prominent at cartilage erosion sites, and most of the positive specimens demonstrated extracellular enzyme. By contrast, collagenase 3 was observed less frequently (7/28 specimens) and was produced by relatively few chondrocytes and synovial cells, this usually being much less than that observed for chondrocytes of osteoarthritic cartilage. These observations suggest dierent regulatory mechanisms for the production of collagenases 1 and 3 in the rheumatoid lesion, and demonstrate that the distribution and production of collagenase 1 are far more prevalent than those for collagenase 3.
RHEUMATOID arthritis (RA) is a disease characterized by chronic in¯ammation and cartilage destruction, with degradation and loss of ®brillar type II cartilage collagen being a major feature. Three collagenases are known to attack type II collagen, with each enzyme purported to show distinct tissue speci®city within the joint [1] . Collagenase 1 is produced by synovial cells, collagenase 2 by neutrophils, and collagenase 3 by chondrocytes [1±5] . These collagenases share many properties: they are synthesized in latent form, respond to the same inhibitors, degrade collagen types I, II and III, and induce proteolysis of native collagen at the same locus [6, 7] . However, they have diering abilities to degrade the dierent types of collagen; whereas collagenase 1 has greater speci®city for type III and collagenase 2 preferentially cleaves type I collagen, collagenase 3 is reportedly the most ecient enzyme for type II collagen degradation [4, 6] . The relative contributions of each collagenase in the cartilage degradation of rheumatoid joints remain uncertain [1] . Previous reports have demonstrated that collagenase 1 has a variable distribution in human rheumatoid tissues, including sites of cartilage erosion [8] , whilst collagenase 3 appears to be more selectively expressed [5, 9, 10] . It has also been reported that synovial cells do not produce collagenase 3 under normal or pathological conditions [3] ; by contrast, collagenase 3 is purportedly expressed in parallel with collagenase 1 in rheumatoid tissues [11] .
We have used immunolocalization techniques to investigate the ability of human articular chondrocytes and rheumatoid synovial cells to produce these enzymes in vitro. In addition, we have compared the distributions of collagenases 1 and 3 in rheumatoid lesions sampled from 28 patients, both at sites of cartilage erosion and within rheumatoid synovial tissue, and have compared the collagenase 3 ®ndings with those obtained in osteoarthritic cartilage.
MATERIALS AND METHODS

Tissue specimens
Samples of cartilage±pannus junction with overlying rheumatoid synovial tissue were obtained from 28 patients (21 females and seven males) with latestage classic RA undergoing remedial arthroplasty of the knee. Most surgical specimens showed extensive cartilage loss, with denuded bone a common feature, but residual cartilage both with and without overlying rheumatoid synovium was usually available for sampling and represented various stages of cartilage erosion from each joint. In addition, cartilage was sampled from osteoarthritic femoral heads removed at hip replacement surgery for immunolocalization studies. All specimens were ®xed for 1 h in Carnoy's ®xative and conventionally embedded in paran wax.
Chondrocyte cell cultures
Macroscopically normal articular cartilage sampled from rheumatoid arthroplasty material was enzymically digested as previously described [12] . One millilitre of isolated human articular chondrocyte (HAC) suspensions containing H10 4 cells/ml of Dulbecco's modi®ed Eagles medium (DMEM) + 20% fetal calf serum (FCS; Gibco Life Technologies, Paisley) was added to each well of a 12 well culture dish containing a sterile 19-mm-diameter glass coverslip and cultured as previously described [13, 14] . After 48 h, DMEM + 0.25% lactalbumin hydrolysate (LH) containing interleukin-1b (IL-1b) at a ®nal concentration of 0.5 ng/ml was added to half the wells, whilst the rest received fresh DMEM + 0.25% LH. After 16 h, monensin (which inhibits secretion) was added to all the wells at a ®nal concentration of 5 mM and after a further 6 h coverslips were ®xed for 10 min in 70% ethanol, air dried and stored desiccated at 48C until required for immunolocalization.
Synovial cell cultures
Rheumatoid synovial tissue was enzymically dissociated as described previously [13] . One millilitre of a cell suspension containing 10 4 cells/ml of DMEM +10% FCS was added to each well of a 12 well culture dish containing a sterile 19-mm-diameter glass coverslip and cultured as described above. After 24 h the adherent synovial cells (ASC) were washed three times in HBSS to remove non-adherent cells and the medium replenished. After 5 days in culture cells received IL-1b at a ®nal concentration of 0.5 ng/ml in DMEM + 0.25% LH or DMEM + LH alone. After 16 h, monensin was added to the cell cultures prior to ®xation as described above for the chondrocyte cultures.
Immunolocalization procedures
Immunocytochemistry. HAC or ASC, both derived from rheumatoid joints, were rehydrated in Trisbuered saline (TBS) (pH 7.6) and examined for metalloproteinases using rabbit polyclonal antibody to collagenase 1 and mouse monoclonal antibody to collagenase 3 (a generous gift from Dr Peter Mitchell, P®zer, Groton, CT, USA), diluted in TBS 1:50 and 1:200, respectively. Each antibody was shown to have no cross-reactivity to the human metalloproteinases stromelysin 1, gelatinase A and gelatinase B using similar techniques to those described previously [15] , and was shown to be speci®c for the relevant collagenase. The coverslips were incubated with primary antibody for 2 h at 208C. After three 10 min washes in TBS, the cells were treated with¯uorescein isothiocyanate (FITC)-conjugated swine anti-rabbit IgG or goat anti-mouse IgG secondary antibodies (both from Dako, Glostrup, Denmark), and mounted in Immumount (Shandon Scienti®c Ltd, Cheshire).
Dual immunolocalization procedure. A combination of the primary antibodies rabbit anti-collagenase 1 and mouse monoclonal anti-collagenase 3 in TBS was applied to the HAC and ASC coverslips, followed by FITC-conjugated swine anti-rabbit IgG and Texas red-conjugated sheep anti-mouse IgG (Amersham, UK) as described previously [14] .
Tissue sections. Five micrometre tissue sections of cartilage±pannus junctions or osteoarthritic cartilage were cut, dewaxed, rehydrated and examined for the presence of collagenases 1 and 3 using the primary antibodies described above. Tissue sections were ®rst incubated for 30 min in 10% (v/v) serum of the species in which biotinylated antibody was raised. Primary antibodies to collagenases 1 and 3 were applied to sections for 2 h at 208C. After three washes in TBS, biotinylated swine anti-rabbit IgG or biotinylated goat anti-mouse IgG (both from Dako), diluted 1:300, were applied to the sections for 45 min at 208C. After washing (3 Â TBS), avidin±biotin complex (Dako) conjugated to alkaline phosphatase (AP) was applied to the sections for 45 min at 208C and was developed using New Fuchsin. Specimens were described as`positive' for intra-and/or extracellular staining relative to controls as determined by two independent assessors.
Controls
Control incubations included treatments with buer only, or similar dilutions of non-immune sera substituted for the primary antibody. All consistently showed negative results. Conventional epitope unmasking techniques of trypsinization (0.1 mg/ml in 0.1% CaCl 2 in TBS for 20 min at 378C) or microwave treatment (5 min at 850 W) failed to increase the extent of collagenase 3 staining to that described.
Photography
All cells and tissue sections were examined on a Zeiss Photomicroscope III; dual localization was visible through individual ®lter sets for FITC and Texas red, and micrographs were taken using Kodak Ektachrome 160 T colour reversal ®lm.
RESULTS
Chondrocyte cultures
Primary HAC without IL-1b stimulation showed that H20% of cells were immunostained for collagenase 1, whereas <5% were positive for collagenase 3. By contrast, HAC cultures treated with IL-1b showed that up to 80% of the cells were positive for collagenase 1, compared to only 5±10% which demonstrated collagenase 3. Dual localization techniques were used to determine whether individual cells were producing one or both of these enzymes under in vitro conditions. Although the majority of cells were found to produce only one enzyme (Fig. 1A and B), some chondrocytes were shown to produce both the collagenases, as judged by intracellular immunostaining (Fig. 1C and D) .
Rheumatoid synovial cells
Primary ASC cultures, comprising a mixture of both synovial ®broblasts and macrophages (CD68 positive), demonstrated variable collagenase 1 immunostaining: whereas from 10 to 60% of the ®broblastic cells were positive for collagenase 1 production, the macrophages were devoid of enzyme. Collagenase 3, however, was consistently absent from these cell cultures. Subcultures of rheumatoid synovial ®broblasts (passage numbers 1±4) were examined for immunodetection of collagenases 1 and 3, after treatment with IL-1b. Whereas >95% of the ®broblasts were shown to be positive for collagenase 1, no evidence was found for collagenase 3 production ( Fig. 1E and F) .
Rheumatoid tissues
Collagenase 3 was demonstrated by immunostaining in seven of the 28 rheumatoid tissue specimens.
Chondrocytes were occasionally found to contain the enzyme (Fig. 2) , and a few positive cells were observed at the cartilage±pannus junction of one specimen, but the tissue origin of these cells is uncertain (Fig. 2B) . Tissue sections were generally negative for collagenase 3 and weak extracellular staining was seen in only one specimen. In contrast to these results for collagenase 3, collagenase 1 was localized both extracellularly and intracellularly in a majority of the specimens examined. Several showed localized areas of extracellular staining at the cartilage±pannus junction and within the synovial tissue. Cells in the synovium often showed intracellular staining, and four of the 28 specimens showed evidence of chondrocytes producing collagenase 1 (Fig. 2) . However, it was often noted that individual chondrocytes exhibited quite dierent collagenase phenotypes within any one area, with some cells strongly stained for collagenase 1 or collagenase 3 adjacent to chondrocytes negative for enzyme ( Fig. 2C and D) . Assessment of the distributions of both enzymes in synovial tissues showed a preponderance of cells stained for collagenase 1 rather than collagenase 3 ( Fig. 2E and F) . Table I provides an overall assessment of the relative frequency and distribution sites for the two collagenases compiled from the immunohistochemical observations of the 28 rheumatoid specimens.
In contrast to the observations of collagenase 3 iǹ rheumatoid' cartilage, the immunostaining for this enzyme was much more common in the chondrocytes of eight dierent specimens of osteoarthritic cartilage ( Fig. 2G and H) . Whilst ®ve OA cartilage specimens showed H60% of chondrocytes positively stained, the remainder showed relatively little collagenase 3 staining.
DISCUSSION
The matrix metalloproteinases are known to degrade various components of the cartilage matrix [16] and several have been demonstrated in rheumatoid tissues, either by immunolocalization [17] or by in situ hybridization [18, 19] . Whereas a role for collagenase 1 and stromelysin 1 in cartilage destruction of rheumatoid joints has been substantiated by their demonstration at cartilage erosion sites [8, 20] , the contribution of collagenase 3 (MMP-13) remains obscure [1] . Collagenase 3 has been shown to have a broad spectrum of activity against extracellular matrix proteins; this includes collagenolytic as well as gelatinolytic activity [6] , degradation of cartilage aggrecan [21] , and an ability to degrade cartilage type II collagen preferentially [4, 6] . By contrast, the more speci®c ®broblast collagenase 1, preferentially degrades collagens type III and I, with type II collagen being degraded approximately ®ve times more slowly than type I [22] . Since collagenase 3 is characteristically produced by activated chondrocytes in vitro [4, 5] , and by chondrocytes of osteoarthritic cartilage [3, 23] , it seemed likely that this enzyme would play an important role in cartilage destruction associated with the rheumatoid lesion. However, our immunohistochemical ®ndings have demonstrated that collagenase 3 was produced in only a minority of the rheumatoid specimens examined, in contrast to the higher frequencies observed for osteoarthritic cartilage and the wider and more frequent distributions for collagenase 1.
Almost all studies on collagenase 3 expression and production in arthritic joint tissue or cells have been based on mRNA analyses or enzyme production monitored by Western blotting techniques. Such studies have shown that human chondrocytes express mRNA for collagenase 3, this being upregulated by the pro-in¯ammatory cytokines IL-1b and tumour necrosis factor alpha (TNF-a) [3, 5, 23] , and that more collagenase 3 protein is produced by chondrocytes from osteoarthritic cartilage [3, 4] . Whereas some studies have found little evidence for collagenase 3 expression by synoviocytes [3, 5] , Wernicke et al. [11] showed that mRNA for collagenase 3 could be demonstrated in a proportion of arthritic synovial membranes, in parallel with mRNA for collagenase 1 and stromelysin 1. To date, only one abstract [24] has reported immunolocalization studies of collagenase 3 in a limited number of arthritic tissues, claiming lower levels in cartilage from RA compared to osteoarthritis; our ®ndings for osteoarthritic cartilage are in accord with those data. Our observations from cell cultures con®rm earlier studies [3, 5, 23] that the pro-in¯ammatory cytokines upregulate collagenase 3 production by chondrocytes, but do not induce collagenase 3 production by synoviocytes [3, 5] . By contrast, collagenase 1 is markedly stimulated by these cytokines in both chondrocyte and synoviocyte cultures. Our observations have shown a relative paucity of collagenase 3 iǹ rheumatoid' cartilage specimens and its occasional production by a few synoviocytes. Collagenase 3 production was invariably restricted to single or very small groups of cells, observations in contrast to the more frequent staining of osteoarthritic chondrocytes. The stimulatory factors responsible for this collagenase 3 response by some cells in vivo remain unclear, but it would seem from the rheumatoid tissues that the full stimulatory requirements are dissimilar to those which regulate collagenase 1 production. As yet, we have no evidence for the coordinate production of both enzymes by individual cells of the rheumatoid lesion, although this has been demonstrated by activated`rheumatoid' chondrocytes in vitro.
The reports of high levels of collagenase 3 expression in`osteoarthritic' chondrocytes are in accord with the prime role for these cells in this degenerative cartilage disease, and are supported by the observations of osteoarthritic cartilage sections in this study. By contrast, histological studies of RA tissues have shown that chondrocyte-mediated chondrolysis is relatively infrequent, the invasive synovial tissue providing most of the degradative processes involved in cartilage erosion [25±27] . We conclude that collagenase 1 production appears to be more prevalent than that for collagenase 3 in the rheumatoid lesion, and that these visual immunolocalization observations provide a new perspective on the previous biochemically based studies of collagenase 1 and 3 expression in rheumatoid tissues and cells.
NOTE ADDED IN PROOF
While this paper was`in press' we became aware of the publication by Lindy et al. [28] which examined the distribution of collagenase-3 in six specimens of rheumatoid synovium and seven specimens of osteoarthritic synovium. Lindy et al. reported a very high incidence of positive staining for collagenase 3, viz. 86% of rheumatoid synovial lining and endothelial cells, and a similar frequency for stained lining and endothelial cells in osteoarthritic synovial tissues. These observations are in direct contrast to the data presented here, where we found no evidence for collagenase 3-positive endothelial cells, and only five of 28 rheumatoid synovial specimens showed relatively few cells (<5%) stained for collagenase 3. At present the reasons for these major differences between the two papers remain uncertain, but may relate to different antibody preparations, specificities and the methodology for immunostaining.
